Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways

Background:Wilms' tumour 1 (WT1) gene was discovered as a tumour suppressor gene. Later findings have suggested that WT1 also can be oncogenic. This complexity is partly explained by the fact that WT1 has a number of target genes.Method:WT1 and its target gene human telomerase reverse transcriptase (hTERT) were analysed in clear cell renal cell carcinoma (ccRCC). In vitro experiments were performed to examine the functional link between WT1 and hTERT by overexpression of WT1 isoforms in the ccRCC cell line, TK-10.Results:WT1 demonstrated lower RNA expression in ccRCC compared with renal cortical tissue, whereas hTERT was increased, showing a negative correlation between WT1 and hTERT (P=0.005). These findings were experimentally confirmed in vitro. The WT1 generated effect on hTERT promoter activity seemed complex, as several negative regulators of hTERT transcription, such as SMAD3, JUN (AP-1) and ETS1, were activated by WT1 overexpression. Downregulation of potential positive hTERT regulators, such as cMyc, AP-2α, AP-2γ, IRF1, NFX1 and GM-CSF, were also observed. Chromatin immunoprecipitation analysis verified WT1 binding to the hTERT, cMyc and SMAD3 promoters.Conclusion:The collected data strongly indicate multiple pathways for hTERT regulation by WT1 in ccRCC.

[1]  D. Loeb,et al.  Isoforms of Wilms’ tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells , 2007, Oncogene.

[2]  J. Barrett,et al.  DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. , 1999, Cancer research.

[3]  I. Kawase,et al.  Immunohistochemical detection of WT1 protein in a variety of cancer cells , 2006, Modern Pathology.

[4]  J. Lachuer,et al.  Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells. , 2009, Carcinogenesis.

[5]  R. Colvin,et al.  Diagnosis and management of renal cell carcinoma A clinical and pathologic study of 309 cases , 1971, Cancer.

[6]  O. Ogawa,et al.  The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. , 2005, The Journal of urology.

[7]  Holger Moch,et al.  The Heidelberg classification of renal cell tumours , 1997, The Journal of pathology.

[8]  M. Yutsudo,et al.  Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. , 1999, Cancer research.

[9]  Xin-Yuan Fu,et al.  Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor. , 2006, Cancer research.

[10]  J. Finke,et al.  Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma , 1998, International journal of cancer.

[11]  M. L. Le Beau,et al.  Structure and chromosomal localization of the functional intronless human JUN protooncogene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Yim,et al.  The Wilms' Tumor 1 Tumor Suppressor Gene Represses Transcription of the Human Telomerase Reverse Transcriptase Gene* , 1999, The Journal of Biological Chemistry.

[13]  L. Sobin,et al.  The TNM system: Our language for cancer care , 2002, Journal of surgical oncology.

[14]  T. Kiyono,et al.  Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. , 2004, Genes & development.

[15]  S. Ariyaratana,et al.  The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis , 2007, Expert Reviews in Molecular Medicine.

[16]  K. Crabtree.  Wilms Tumor: Status Report, 1990 , 1992 .

[17]  Xiang-Jiao Yang,et al.  Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. , 2008, Cellular signalling.

[18]  G. Kovacs.  Molecular genetics of human renal cell tumours. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  M. Minden,et al.  A tumor suppressor and oncogene: the WT1 story , 2007, Leukemia.

[20]  Dakang Xu,et al.  Transcriptional Regulation of Telomerase Activity , 2007, Annals of the New York Academy of Sciences.

[21]  S. Goodison,et al.  Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells. , 2003, Molecular cancer research : MCR.

[22]  R. Dalla‐Favera,et al.  Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.

[23]  D. Housman,et al.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor , 1990, Cell.

[24]  Wei Zhang,et al.  Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-γ induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression , 2003, Oncogene.

[25]  J. Roth,et al.  Tumor-specific Activation of Human Telomerase Reverses Transcriptase Promoter Activity by Activating Enhancer-binding Protein-2β in Human Lung Cancer Cells* , 2007, Journal of Biological Chemistry.

[26]  C. B. Patel,et al.  Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. , 2001, Cancer research.

[27]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[28]  H. Yoshikawa,et al.  Overexpression of the Wilms' tumor gene WT1 in human bone and soft‐tissue sarcomas , 2003, Cancer science.

[29]  尾路 祐介.  OVEREXPRESSION OF THE WILMS' TUMOR GENE WT1 IN DE NOVO LUNG CANCERS , 2003 .

[30]  A. Gurney,et al.  Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. , 1996, The EMBO journal.

[31]  D. Haber,et al.  Functional properties of WT1. , 1996, Medical and pediatric oncology.

[32]  Y. Sonoda,et al.  Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. , 1997, Blood.

[33]  M. Cam,et al.  Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney Development* , 2007, Journal of Biological Chemistry.

[34]  M. Bellon,et al.  Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. , 2008, Blood.

[35]  Amy Bernard,et al.  Physical and functional interaction between WT1 and p53 proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Jochemsen,et al.  WT1 proteins: functions in growth and differentiation. , 2001, Gene.

[37]  D. Dimitrov,et al.  Role of Ets/Id proteins for telomerase regulation in human cancer cells. , 2003, Experimental and molecular pathology.

[38]  T. Shimizu,et al.  Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells. , 2000, Anticancer research.

[39]  N. Hosen,et al.  Wilms’ tumor gene WT1 17AA(–)/KTS(–) isoform induces morphological changes and promotes cell migration and invasion in vitro , 2006, Cancer science.

[40]  B. Hallberg,et al.  The PTEN regulator DJ‐1 is associated with hTERT expression in clear cell renal cell carcinoma , 2009, International journal of cancer.

[41]  J. Pelletier,et al.  Identification of nuclear localization signals within the zinc fingers of the WT1 tumor suppressor gene product , 1996, FEBS letters.

[42]  M. Minden,et al.  Transcriptional activation of c-myc proto-oncogene by WT1 protein , 2004, Oncogene.

[43]  Satoru Kyo,et al.  Function of AP-1 in Transcription of the Telomerase Reverse Transcriptase Gene (TERT) in Human and Mouse Cells , 2005, Molecular and Cellular Biology.

[44]  M. Sopta,et al.  Telomerase regulation at the crossroads of cell fate , 2009, Cytogenetic and Genome Research.

[45]  S M Hewitt,et al.  Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. , 1995, Cancer research.

[46]  M Kitagawa,et al.  Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 , 1993, Science.

[47]  K. Wagner,et al.  The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo , 2008, Oncogene.

[48]  D. Housman,et al.  Alternative splicing and genomic structure of the Wilms tumor gene WT1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  W. Keith,et al.  Telomerase upregulation is a postcrisis event during senescence bypass and immortalization of two Nijmegen breakage syndrome T cell cultures , 2010, Aging cell.